Concepedia

Publication | Open Access

Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial

DOIFull Paper Access

316

Citations

22

References

2002

Year

James W. Anderson, Frank L. Greenway, Ken Fujioka, Kishore M. Gadde, James M. McKenney, Patrick M. O’Neil
Obesity Research

Abstract

Bupropion SR 300 and 400 mg/d were well-tolerated by obese adults and were associated with a 24-week weight loss of 7.2% and 10.1% and sustained weight losses at 48 weeks.

References

YearCitations

Page 1